Vaccine Against Alzheimer's Disease Protein Passes First Stage Of Clinical Trials
A vaccine plan to protect against Alzheimer ’s disease has passed the first stage of clinical trials . It join many other offer dementedness treatments , all jostle to ease the fears of an maturate population , but aim a dissimilar vista of the disease . Its designer think this may see it annul the side - essence that have stanch many other tribulation . InLancet Neurologya squad lead byDr Petr Novakof AXON Neuroscience , Slovakia , has announced the vaccine induced the desire resistant response in 29 of 30 patients with meek - to - temperate Alzheimer ’s ....